Obstetric Pharmacokinetic Dosing Studies are Urgently Needed
Authors:
Open Access
- 1 January 2014
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 2, 9
Abstract
Use of pharmacotherapy during pregnancy is common and increasing. Physiologic changes during pregnancy may significantly alter overall systemic drug exposure, necessitating dose changes. A search of PubMed for pharmacokinetic studies showed 494 publications during pregnancy out of 35,921 total pharmacokinetic published studies (1.29%), from the late 1960s through August 31, 2013. Closer examination of pharmacokinetic studies in pregnant women published since 2008 (81 studies) revealed that about a third of the trials were for treatment of acute labor and delivery issues, a third included studies of infectious disease treatment during pregnancy, and the remaining third were for varied antepartum indications. Approximately two-thirds of these recent studies were primarily funded by government agencies worldwide, one quarter were supported by private non-profit foundations or combinations of government and private funding, and slightly less than 10% were supported by pharmaceutical industry. As highlighted in this review, vast gaps exist in pharmacology information and evidence for appropriate dosing of medications in pregnant women. This lack of knowledge and understanding of drug disposition throughout pregnancy place both the mother and the fetus at risk for avoidable therapeutic misadventures – suboptimal efficacy or excess toxicity – with medication use in pregnancy. Increased efforts to perform and support obstetric dosing and pharmacokinetic studies are greatly needed.Keywords
This publication has 109 references indexed in Scilit:
- Effects of Discontinuing Anti–Tumor Necrosis Factor Therapy During Pregnancy on the Course of Inflammatory Bowel Disease and Neonatal ExposureClinical Gastroenterology and Hepatology, 2013
- Preliminary Buprenorphine Sublingual Tablet Pharmacokinetic Data in Plasma, Oral Fluid, and Sweat During Treatment of Opioid-Dependent Pregnant WomenTherapeutic Drug Monitoring, 2011
- Pharmacokinetics and Placental Transfer of Single-Dose Tenofovir 1% Vaginal Gel in Term PregnancyThe Journal of Infectious Diseases, 2011
- Methadone, Cocaine, Opiates, and Metabolite Disposition in Umbilical Cord and Correlations to Maternal Methadone Dose and Neonatal OutcomesTherapeutic Drug Monitoring, 2011
- Doxorubicin and ifosfamide for high-grade sarcoma during pregnancyCancer Chemotherapy and Pharmacology, 2011
- A two-center study on the pharmacokinetics of intravenous immunoglobulin before and during pregnancy in healthy women with poor obstetrical historiesHuman Reproduction, 2011
- Pharmacokinetics of oseltamivir among pregnant and nonpregnant womenAmerican Journal of Obstetrics and Gynecology, 2011
- Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai womenJournal of Antimicrobial Chemotherapy, 2009
- Are We Optimizing Gestational Diabetes Treatment With Glyburide? The Pharmacologic Basis for Better Clinical PracticeClinical Pharmacology & Therapeutics, 2009
- Implications of gender and pregnancy for antiretroviral drug dosingCurrent Opinion in HIV and AIDS, 2008